Marine Natural Products as Potent Anticancer Agents (2020–2024): Structural Diversity, SARs and Target Prediction
Marine Drugs · 10.05.2026 · 24 (5) · 173
DOI: 10.3390/md24050173 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Marine Drugs, online erschienen am 10.05.2026. Verfasst von Zimeng Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Science & Jianxing Honors College, Zhejiang University of Technology, Hangzhou 310014, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Aquatic Organisms, Biological Products, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
In recent years, Marine Natural Products (MNPs) have emerged as a significant source for anticancer drug discovery, as many natural products can offer structural diversity, unique mechanisms of action, and relatively low toxicity. This article provides a systematic review of MNPs with reported anticancer activities from 2020 to 2024. These compounds are classified into seven major categories: terpenoids, alkaloids, sterols, polyketides, peptides and proteins, polysaccharides, and macrolides. For each category, we elaborate on the marine sources, structural identification, in vitro anticancer activity, and preliminary structure–activity relationships. We found that sponges and marine-derived fungi are the most abundant sources of highly active compounds. Furthermore, knowledge graph-based analysis reveals that oxygen- and nitrogen-containing heterocycles constitute the core pharmacophores, and target prediction further indicates that MNPs exert anticancer effects through coordinated modulation of a multi-target network involving kinases, proteasomes, and nuclear receptors. This review contributes significantly to a deeper understanding of recent advances (2020–2024) in MNPs and provides critical guidance for promoting the development of innovative anticancer drugs derived from marine resources.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Science & Jianxing Honors College, Zhejiang University of Technology, Hangzhou 310014, China.
- Zhejiang-Egypt Joint Laboratory on Intelligent Discovery of Marine Drugs, Hangzhou 310014, China.
- Zhejiang Key Laboratory of Green Manufacturing Technology for Chemical Drugs, Hangzhou 310014, China.
ORCID-Profile: Junzhe Hu, Hong Wang, Zhikun Yang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Huang, Z., Du, Y., Hu, J., Ying, L., Zhou, B., Hua, Y., Wang, H., & Yang, Z. (2026). Marine Natural Products as Potent Anticancer Agents (2020–2024): Structural Diversity, SARs and Target Prediction. Marine Drugs, 24(5), 173. https://doi.org/10.3390/md24050173
Vancouver
Huang Z, Du Y, Hu J, Ying L, Zhou B, Hua Y, et al. Marine Natural Products as Potent Anticancer Agents (2020–2024): Structural Diversity, SARs and Target Prediction. Marine Drugs. 2026;24(5):173. doi:10.3390/md24050173
BibTeX
@article{Huang2026,
author = {Huang, Zimeng and Du, Yijing and Hu, Junzhe and Ying, Leyi and Zhou, Binying and Hua, Yi and Wang, Hong and Yang, Zhikun},
title = {Marine Natural Products as Potent Anticancer Agents (2020–2024): Structural Diversity, SARs and Target Prediction},
journal = {Marine Drugs},
year = {2026},
volume = {24},
number = {5},
pages = {173},
doi = {10.3390/md24050173}
}
EUVIMED